Kenya and Uganda are among the countries selected for the Phase 1 clinical trial of an HIV vaccine. According to the Globally Relevant AIDS Vaccine Europe-Africa Trials Partnership (GREAT), the first dose will be given in Lusaka, Zambia while Kenya and Uganda will receive the vaccines in a few weeks. Dr. William Kilembe, project director of the Center for
Subscribe to unlock this article
Digital Subscription – Monthly
Monthly renewing
You can cancel anytime.
$5 /Monthly
Digital Subscription – Annually
Monthly renewing
You can cancel anytime.
$40 /Annually
